Skip to main content
Menu
Find Your Relief

Spectra WaveWriter™ 

Spinal Cord Stimulator (SCS) System

The right therapy, right where you need it

With the Spectra WaveWriter SCS System, multiple therapies can be used to treat multiple pain areas at the same time.*

Multiple therapies. One device. More personal relief.

Paresthesia

Some SCS therapies replace the feeling of pain with a soothing massage-like sensation called paresthesia.1

Paresthesia-free

Other SCS therapies treat pain without paresthesia, using a type of stimulation you can’t feel.1

Both Combined

The Spectra WaveWriter SCS System combines both options in a single device. Clinical research shows that patients can achieve superior long-term outcomes when they can choose between multiple therapy options.1

Broader coverage of your unique pain area

To get the best possible pain relief, your SCS system needs to be able to target the right part of your spinal cord. The Spectra WaveWriter SCS System features advanced software and leads with up to 32 contacts that are designed to cover a wider area of the spine than conventional systems. This makes it easier to find your unique pain relief “target”—and to maintain therapy in the right spot if the target moves over time.

Real-time therapy feedback

The Spectra WaveWriter SCS System allows you to partner with your doctor to get even more personalized treatment. The system can be programmed to automatically rotate through different types of stimulation. You can then rate the changing therapies in real time using your remote. The system generates a ratings report that helps your doctor see what treatments work best for your unique pain.

Personalized treatment. Lasting results.

Boston Scientific SCS patients reported a nearly 6-point drop in pain score, even after two years.2

Try your relief first

Before committing to SCS, find out if it will work for you by taking it for a “test drive” with a temporary trial system.

Learn About the SCS Trial 

Real success stories

Chris

“Boston Scientific offers a lot of options—a paresthesia or a nonparesthesia—and I chose paresthesia. I was hurting for so long, I didn’t want to just not feel anything. It’s very personal. It’s what helps you.”

Watch Chris' Story

Gregory

“I really feel that my pain relief has been personalized to me just because of the different settings that I have with my stimulator.”

Watch Gregory's Story

Karen

“The settings can be ones where you can feel the paresthesia or you don’t feel anything at all. For me, the settings that address my pain the most are the ones that I don’t feel any of the paresthesia, but that flexibility is very comforting.”

Watch Karen's Story

Neil

“When the stimulator was turned on, I had tears of joy running down both cheeks.”

Watch Neil's Story

Mary

“From the moment that I got the device in the trial, for the first time in years I felt immediate relief. It felt like I had a new lease on life.”

Watch Mary's Story

Talk to a real patient living with SCS therapy

Connect with real people living with pain and hear about their experience finding lasting relief by using a Boston Scientific solution.

Contact an Ambassador

Find a pain management doctor near you

Use our Doctor Locator to explore pain management specialists in your area. 

Start your search. ⟶

image of navigation map
Search

Learn about SCS with the mySCS™ app

Designed to help patients during their SCS trial, this free app also includes informative articles and resources on SCS for wherever you are on your journey.

Explore the mySCS App

Wondering if the Spectra WaveWriter SCS System may be right for you?

Take this quick quiz and find out. ⟶

*Paresthesia-free stimulation has been shown to be safe and effective in patients who have been treated successfully with paresthesia-inducing stimulation for at least 6 months.

References: 1. North J, Loudermilk E, Lee A, et al. Outcomes of a multicenter, prospective, crossover, randomized controlled trial evaluating subperception spinal cord stimulation at ≤1.2 kHz in previously implanted subjects. Neuromodulation. 2020;23(1):102-108. 2. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS—LUMINA Study. Pain Med. 2017;18(8):1534-1548.

Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.

Indications for Use: The Boston Scientific Spinal Cord Stimulator Systems are indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, intractable low back pain and leg pain, Diabetic Peripheral Neuropathy of the lower extremities, radicular pain syndrome, radiculopathies resulting in pain secondary to failed back syndrome or herniated disc, epidural fibrosis, degenerative disc disease (herniated disc pain refractory to conservative and surgical interventions), arachnoiditis, multiple back surgeries. The Boston Scientific Spectra WaveWriter™, WaveWriter Alpha™ and WaveWriter Alpha™ Prime SCS Systems are also indicated as an aid in the management of chronic intractable unilateral or bilateral low back and leg pain without prior back surgery.

Contraindications. The Spinal Cord Stimulator systems are not for patients who are unable to operate the system, have failed trial stimulation by failing to receive effective pain relief, are poor surgical candidates, or are pregnant.

MR Conditional symbol

Boston Scientific’s ImageReady™ MRI Technology makes safe MRI head scans possible. Patients implanted with the Precision Spectra™ or Spectra WaveWriter™ Spinal Cord Stimulator Systems with ImageReady™ MRI Technology are "MR Conditional" only when exposed to the MRI environment under the specific conditions defined in the applicable ImageReady™ MRI Head Only Guidelines for Precision Spectra™ or Spectra WaveWriter™ Spinal Cord Stimulator Systems.

MR Conditional symbolBoston Scientific’s ImageReady™ MRI Full Body Technology makes safe MRI scans possible. The Precision Montage™ MRI, WaveWriter Alpha™ and WaveWriter Alpha™ Prime SCS Systems with ImageReady™ MRI Full Body Technology are “MR Conditional” only when exposed to the MRI environment under the specific conditions defined in the applicable ImageReady™ MRI Full Body Guidelines for Precision Montage™ MRI or WaveWriter Alpha™ and WaveWriter Alpha™ Prime Spinal Cord Stimulator Systems.

Warnings. Patients implanted with Boston Scientific Spinal Cord Stimulator Systems without ImageReady™ MRI Technology should not be exposed to Magnetic Resonance Imaging (MRI). Exposure to MRI may result in dislodgement of the stimulator or leads, heating of the stimulator, severe damage to the stimulator electronics and an uncomfortable or jolting sensation. As a Spinal Cord Stimulation patient, you should not have diathermy as either a treatment for a medical condition or as part of a surgical procedure. Strong electromagnetic fields, such as power generators or theft detection systems, can potentially turn the stimulator off, or cause uncomfortable jolting stimulation. The system should not be charged while sleeping. The Spinal Cord Stimulator system may interfere with the operation of implanted sensing stimulators such as pacemakers or implanted cardiac defibrillators. Advise your physician that you have a Spinal Cord Stimulator before going through with other implantable device therapies so that medical decisions can be made and appropriate safety measures taken. Patients using therapy that generates paresthesia should not operate motorized vehicles such as automobiles or potentially dangerous machinery and equipment with the stimulation on. Stimulation must be turned off first in such cases. For therapy that does not generate paresthesia (i.e. subperception therapy) it is less likely that sudden stimulation changes resulting in distraction could occur while having stimulation on when operating moving vehicles, machinery, and equipment. Your doctor may be able to provide additional information on the Boston Scientific Spinal Cord Stimulator systems.  For complete indications for use, contraindications, warnings, precautions, and side effects, call 866.360.4747 or visit Pain.com. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Indications for Use: The Superion™ Indirect Decompression System (IDS) is indicated to treat skeletally mature patients suffering from pain, numbness, and/or cramping in the legs (neurogenic intermittent claudication) secondary to a diagnosis of moderate degenerative lumbar spinal stenosis, with or without Grade 1 spondylolisthesis, having radiographic evidence of thickened ligamentum flavum, narrowed lateral recess, and/or central canal or foraminal narrowing. The Superion™ Interspinous Spacer is indicated for those patients with impaired physical function who experience relief in flexion from symptoms of leg/buttock/groin pain, with or without back pain, who have undergone at least 6 months of non-operative treatment. The Superion Interspinous Spacer may be implanted at one or two adjacent lumbar levels in patients in whom treatment is indicated at no more than two levels, from L1 to L5. Contraindications, warnings, precautions, side effects. The Superion Indirect Decompression System (IDS) is contraindicated for patients who: have spinal anatomy that prevent implantation of the device or cause the device to be unstable in situ (i.e., degenerative spondylolisthesis greater than grade 1), Cauda equina syndrome, or prior decompression or fusion at the index level, scoliosis or spinous process fractures, osteoporosis, infection, allergy or reaction to any metal or implant or a high Body Mass Index. Avoid strenuous activity for 6 weeks after surgery, contact your physician if there is fluid leaking from your incision, if you have pain, swelling or numbness in your legs or buttocks or if you fall. Refer to the Instructions for Use provided on www.vertiflex.com for additional Indications for Use, contraindications information and potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Indications for Use: The Boston Scientific Radiofrequency Generators, associated Radiofrequency Lesion Probes and RF Cannula are indicated for use in procedures to create radiofrequency lesions for the treatment of pain or for lesioning nerve tissue for functional neurosurgical procedures. The Boston Scientific RF Injection Electrodes are used for percutaneous nerve blocks with local anesthetic solution for radiofrequency lesioning of peripheral nerve tissue only. The Boston Scientific LCED and Stereotactic TCD Electrodes are indicated for use in radiofrequency (RF) heat lesioning of nervous tissue including the Central Nervous System.

Warnings: The Boston Scientific RF devices may cause interference with active devices such as neurostimulators, cardiac pacemakers, and defibrillators. Interference may affect the action of these active devices or may damage them. For appropriate guidance, consult the instructions for use for these active devices. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

§The physician locator tool identifies pain management specialists in your area who have met certain qualifying criteria and are experienced with one or more of Boston Scientific pain management therapies. All treatment options should be discussed thoroughly with a pain management specialist.